Contractor Update: Further products reclassified as special containers from January 2021

Contractor Update: Further products reclassified as special containers from January 2021

January 8, 2021

Following a review of the special container status of certain products, the Department of Health of Social Care (DHSC) has re-determined that a further 14 products for January 2021 now meet the special container criteria as set out in Part II Clause 10B of the Drug Tariff.

Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container
Cabozantinib 20mg tablets Cabometyx (Ipsen Ltd) 30 Complete pack
Cabozantinib 40mg tablets Cabometyx (Ipsen Ltd) 30 Complete pack
Cabozantinib 60mg tablets Cabometyx (Ipsen Ltd) 30 Complete pack
Emtricitabine 200mg / Tenofovir 245mg tablets Mylan 30 (3 x 10) Sub-pack of 10
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution Kaletra (AbbVie Ltd) 120ml (2 x 60ml)
300 ml (5 x 60ml)
Sub-pack of 60ml
Pramipexole 0.26mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 0.52mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 1.05mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 1.57mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 2.1mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 2.62mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pramipexole 3.15mg modified-release tablets Oprymea (Consilient Health Ltd) 30 (3 x 10) Sub-pack of 10
Pheburane 483mg/g granules Eurocept International bv 174 gram Complete pack
Regorafenib 40mg tablets Stivarga (Bayer Plc) 84 (3 x 28) Sub-pack of 28

To date a total of 92 products have now been reclassified as special containers. For a list of all the monthly changes to the special container status of products please see the following page Notice of changes to special container status of products.

Where a product meets the special container criteria (see Background section) as set out in the Drug Tariff, a special container indicator for the relevant pack size (complete pack or sub-pack) is applied to the respective product entries in dictionary of medicines and devices (dm+d) and in the Drug Tariff, where listed. To assist pharmacy teams and provide full visibility PSNC will provide monthly updates on products that are reclassified as special containers.


If you identify any particular product(s) which are not currently classed as special containers but you believe satisfy the criteria (as set out in Part II CLAUSE 10 B of the Drug Tariff), please notify PSNC’s Dispensing and Supply Team (0203 1220 810 or info@psnc.org.uk) who will investigate and assess if it meets the relevant criteria. Where appropriate, PSNC will make application to the NHSBSA and DHSC seeking for the special container status of the product(s) to be re-determined.

 



Posted in: ,


More Latest News >

PSNC launches GP CPCS animation

PSNC has launched a video animation and infographic explaining how GP practices can refer into the NHS Community Pharmacist Consultation...